| 論文種別 | 総説 |
| 言語種別 | 英語 |
| 査読の有無 | その他(不明) |
| 表題 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2024 for the Clinical Practice of Inflammatory Bowel Disease-Associated Intestinal Neoplasia (English Version). |
| 掲載誌名 | 正式名：Journal of the anus, rectum and colon 略 称：J Anus Rectum Colon ISSNコード：24323853/24323853 |
| 巻・号・頁 | 10(1),pp.135-168 |
| 著者・共著者 | Soichiro Ishihara, Shinji Tanaka, Toshio Uraoka, Yutaka Saito, Hiroyuki Takamaru, Hiroshi Nakase, Makoto Naganuma, Tadakazu Hisamatsu, Toshimitsu Fujii, Minoru Matsuura, Takayuki Matsumoto, Kenji Watanabe, Hiroki Ikeuchi, Motoi Uchino, Yoshiki Okita, Koji Okabayashi, Kazutaka Koganei, Akira Sugita, Kenichi Takahashi, Keisuke Hata, Daijiro Higashi, Kitaro Futami, Keiji Matsuda, Tsunekazu Mizushima, Yusuke Watadani, Hiroshi Kawachi, Masayuki Shimoda, Tamotsu Sugai, Masahiro Yoshida, Naohiko Yamaguchi, Michio Itabashi, Hiroyuki Anzai, Junko Kishikawa, Koichi Komatsu, Takahide Shinagawa, Tatsuya Tsushima, Tatsuki Noguchi, Satoshi Okada, Kenichi Sugihara, Yoichi Ajioka |
| 発行年月 | 2026/01 |
| 概要 | The number of patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), continues to increase in many countries and regions. With recent rapid advances in medical therapies targeting intestinal inflammation, the number of patients with long-term disease duration is also increasing. It is well-recognized that longstanding IBD carries an increased risk of developing gastrointestinal (GI) neoplasia, particularly colorectal cancer. However, compared to sporadic GI tumors, IBD-associated GI tumors are relatively rare, and even among specialists in GI diseases, opportunities to encounter such cases remain limited. In light of this situation, the Japanese Society for Cancer of the Colon and Rectum (JSCCR), in collaboration with the Japanese Inflammatory Bowel Disease Research Group (funded by the Japan Sciences Research Grant for Research on Intractable Diseases affiliated with the Ministry of Health, Labour, and Welfare) launched the Guideline Development Committee for IBD-associated Gastrointestinal Tumors in 2021, with the aim of establishing clinical practice guidelines to support the diagnosis and management of these tumors. The committee-comprising experts in gastroenterology, surgery, pathology, guideline development, and literature review-conducted extensive discussions and successfully published the first Japanese edition of the guidelines in July 2024. We believe that the current edition provides the best possible guidance based on presently available knowledge. Furthermore, the guideline development process highlighted several key issues to be addressed in future research and clinical practice. We are pleased to present here the English version of the JSCCR Guidelines 2024 for the Clinical Practice of IBD-associated Intestinal Neoplasia. |
| DOI | 10.23922/jarc.2025-071 |
| PMID | 41623602 |